Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -2.78% 87.50 85.00 90.00 90.00 87.50 90.00 15,829 16:11:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 103

Shield Therapeutics Share Discussion Threads

Showing 5651 to 5672 of 6225 messages
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
DateSubjectAuthorDiscuss
22/4/2020
09:30
Btw. Didn’t realise ASK are the gateway to Hong Kong and Taiwan as well as China. Happy days.
peachie 74
22/4/2020
09:26
Cranky - hopefully STX strategy will start to also address the market for self medication iron food supplements such as Active Iron. I had a long conversation with Tim about this in February.
borromini1
22/4/2020
09:22
Btw. Carl resigning is not the first visible result of the H2H review. You don’t know that. Probably has F all to do with it. As I have done , please state when you are stating your own thoughts, not facts Borromini
peachie 74
22/4/2020
09:19
Could well be the signal that a takeover is more likely. Certainly smacks of a board room disagreement about strategy.
nobbygnome
22/4/2020
09:18
Good point At the end of today’s RNS it still states US , China and the fact it’s a viable alternative to IV. Cannot be coincidence of price rise of recent days, then this. TOTALLY MY THOUGHTS .... people finding out about ? Takeover. And this is why Carl is walking as the one man who is against but powerless to stop and knows he can’t screw friends and colleagues out of money by stopping it. I know , this is postulating and not based on any facts. DYOR. GLA. Exciting !
peachie 74
22/4/2020
09:16
Have seen instances of this before. BTG, with it's varicose vein treatment went to a buy out, from memory. I've also seen, first hand, company founders with majority stakes saying their company will definitely remain independent, only to be sold some time later. They need to get on with it now, optimum window slipping by imho.
daveboy1
22/4/2020
09:14
Carl resigning is the first visible result of the review announced in the previous RNS. A subsequent RNS, with Tim as CEO, will presumably provide more detail on the results of the review. A further clue is to look at changes in how they describe the product at the end of each RNS.
borromini1
22/4/2020
09:08
Reckon Carl was pushed out, could be lining up for a takeover, interesting times ahead imo dyor as usual I would add more but using the money to add more BP shares
ny boy
22/4/2020
09:06
Exactly Monty. Wanted by the Big Investors, not Carl who has built this up. Conflict of interest. Bye Carl. DYOR
peachie 74
22/4/2020
09:05
I feel for those who have had a stop loss triggered and now face difficulty in getting back inTypical MM/NOMAD shenanigans
kop202
22/4/2020
09:04
I agree, something happening, he does not agree with.I reckon bid.
montyhedge
22/4/2020
09:01
If some US company wanted to buy Shield, the man who’s baby it is would surely be the one saying no , stopping the big investors getting what perhaps they want. Pure speculation obviously. But interesting thought
peachie 74
22/4/2020
09:01
peachie this is why they need to hurry the commercial deals as its a great opportunity to market the product because you don't have to go hospital. Just as effective and the overall market is massive. Already FDA approved, no mean feat. Look at the buys!!!
frrinvest
22/4/2020
08:59
Great reaction of share price Few quick sellers thinking it would drop on this news. It’s already ridiculously low. Might struggle to get back in now. Good question steveeee. I see what your saying !!!
peachie 74
22/4/2020
08:58
IV iron costs Relatively high risk of Anaphylactic reaction. Needs to be done in hospital environment with crash facilities Inconvenience. Give me the tablet. Even if it cost more Remember , the MAJORITY of the H2H is not in question showing Feraccru as effective as IV. Just a stupid little error.
peachie 74
22/4/2020
08:56
No one especially now wants to go to hospital, fear of catching Coronavirus. This is the way forward.
montyhedge
22/4/2020
08:56
I wonder if the Americans want more of the company than he was willing to relinquish.
stevee1234
22/4/2020
08:54
Good news imho, so managed to get a few more. DYOR! My wife was telling me this is a brilliant product as it cuts out waiting time - to go hospitals and then waiting for the injection to be administered. There are many many women affected by iron deficiency.
frrinvest
22/4/2020
08:51
But if you have an effective oral treatment for iron deficiency surely over time the number of iv iron treatments will reduce?
kop202
22/4/2020
08:49
Things not moving fast enough for major shareholders so out his goes, onwards and upwards.
montyhedge
22/4/2020
08:37
peachie - because it is slow to take effect and does not have the immediacy, speed and certainty of a single dose of IV Iron. But is still a great product.
borromini1
22/4/2020
08:37
can't buy?
frrinvest
Chat Pages: Latest  237  236  235  234  233  232  231  230  229  228  227  226  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200712 14:10:06